Company / Interest Expense
Moleculin Biotech, Inc. Interest Expense History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$306.0K
FY2022
5-year range
$13.0K / $306.0K
FY2018-FY2022
Trend
+2253.8%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense changed +2254% YoY in FY2022, a notable deviation from the 5-year average annual change of +541%.
Based on SEC 10-K filings.
$306,000 in FY2022 with a 5-year CAGR of +48.1%.
Increased from $13,000 to $306,000 over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +324.5%
- 5-Year CAGR
- +48.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +48.1%, indicating consistent growth.
- In FY2022, interest expense increased 2253.8% year-over-year.
- Lowest interest expense in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -3.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $306.0K | +2253.8% |
| FY2021 | $13.0K | +0.0% |
| FY2020 | $13.0K | +225.0% |
| FY2019 | $4.0K | - |
| FY2018 | $0 | -100.0% |
| FY2017 | $43.0K | +324.4% |
| FY2016 | $10.1K | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026